A078160 Stock Overview
Engages in the cord blood bank business in South Korea and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
MEDIPOST Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩8,330.00 |
| 52 Week High | ₩8,960.00 |
| 52 Week Low | ₩5,450.00 |
| Beta | 0.46 |
| 11 Month Change | 28.55% |
| 3 Month Change | 37.46% |
| 1 Year Change | 3.48% |
| 33 Year Change | -61.61% |
| 5 Year Change | -75.92% |
| Change since IPO | -59.76% |
Recent News & Updates
Subdued Growth No Barrier To MEDIPOST Co., Ltd. (KOSDAQ:078160) With Shares Advancing 29%
Nov 04
Is MEDIPOST (KOSDAQ:078160) Using Debt Sensibly?
Aug 06Recent updates
Subdued Growth No Barrier To MEDIPOST Co., Ltd. (KOSDAQ:078160) With Shares Advancing 29%
Nov 04Is MEDIPOST (KOSDAQ:078160) Using Debt Sensibly?
Aug 06MEDIPOST's (KOSDAQ:078160) Attractive Earnings Are Not All Good News For Shareholders
Mar 27Is MEDIPOST (KOSDAQ:078160) Weighed On By Its Debt Load?
Mar 11MEDIPOST's (KOSDAQ:078160) Stock Price Has Reduced 32% In The Past Three Years
Jan 17Is MEDIPOST (KOSDAQ:078160) A Risky Investment?
Nov 24Shareholder Returns
| A078160 | KR Healthcare | KR Market | |
|---|---|---|---|
| 7D | 14.6% | 3.6% | 2.3% |
| 1Y | 3.5% | -4.4% | -3.8% |
Return vs Industry: A078160 exceeded the KR Healthcare industry which returned -4.4% over the past year.
Return vs Market: A078160 exceeded the KR Market which returned -3.8% over the past year.
Price Volatility
| A078160 volatility | |
|---|---|
| A078160 Average Weekly Movement | 9.4% |
| Healthcare Industry Average Movement | 10.1% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in KR Market | 11.4% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A078160's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A078160's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 299 | n/a | www.medi-post.co.kr |
MEDIPOST Co., Ltd. engages in the cord blood bank business in South Korea and internationally. The company operates through three divisions: Cord Blood Bank, Stem Cell Therapy, and Health Functional Food. It operates cord blood bank under the CELLTREE name.
MEDIPOST Co., Ltd. Fundamentals Summary
| A078160 fundamental statistics | |
|---|---|
| Market cap | ₩284.04b |
| Earnings (TTM) | ₩4.59b |
| Revenue (TTM) | ₩70.01b |
61.9x
P/E Ratio4.1x
P/S RatioIs A078160 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A078160 income statement (TTM) | |
|---|---|
| Revenue | ₩70.01b |
| Cost of Revenue | ₩28.28b |
| Gross Profit | ₩41.73b |
| Other Expenses | ₩37.14b |
| Earnings | ₩4.59b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 134.58 |
| Gross Margin | 59.61% |
| Net Profit Margin | 6.55% |
| Debt/Equity Ratio | 2.9% |
How did A078160 perform over the long term?
See historical performance and comparison